Skip to content

DD T2 Daily Disposable Registration Trial

DD T2 Daily Disposable Registration Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03305770
Enrollment
107
Registered
2017-10-10
Start date
2017-10-12
Completion date
2018-02-21
Last updated
2019-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Refractive Errors

Keywords

soft contact lenses, vision, eyesight

Brief summary

The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.

Detailed description

Enrolled participants will be randomized (2:1) to receive either verofilcon A (test) contact lenses or delefilcon A (control) contact lenses for wear in both eyes and attend 7 office visits: Baseline, Dispense, 1-week follow-up, 2-week follow-up, 1-month follow-up, 2-month follow-up and 3-month follow-up/Exit.

Interventions

Daily disposable soft contact lenses

Daily disposable soft contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Successful wear of spherical soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day. * Best corrected VA 20/25 or better in each eye. * Other protocol-specified inclusion criteria may apply.

Exclusion criteria

* Any current or prior wear experience with DT1 lenses. * Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment. * Other protocol-specified

Design outcomes

Primary

MeasureTime frameDescription
Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense, Week 1, Week 2, Month 1, Month 2, Month 3VA was assessed for each eye individually using a Snellen chart at a distance of 4 meters. A 20/20 Snellen acuity is considered normal distance eyesight. No formal hypotheses were formulated; hence no inferential testing was performed.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from 6 investigational sites located in the US.

Pre-assignment details

This reporting group includes all randomized subjects (107).

Participants by arm

ArmCount
DD T2
Verofilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses were inserted each day and discarded at the end of the day.
70
DT 1
Delefilcon A contact lenses worn in both eyes for 3 months in a daily wear, daily disposable modality. A new pair of study lenses will be inserted each day and discarded at the end of the day.
37
Total107

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision - prior to dispense01
Overall StudySubject moved10

Baseline characteristics

CharacteristicDD T2DT 1Total
Age, Continuous34.3 years
STANDARD_DEVIATION 6.3
31.3 years
STANDARD_DEVIATION 7.6
33.3 years
STANDARD_DEVIATION 6.9
Race/Ethnicity, Customized
American Indian or Alaska Native
0 participants0 participants0 participants
Race/Ethnicity, Customized
Asian
1 participants1 participants2 participants
Race/Ethnicity, Customized
Black or African American
3 participants3 participants6 participants
Race/Ethnicity, Customized
Multi-racial
0 participants0 participants0 participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 participants0 participants0 participants
Race/Ethnicity, Customized
Other
1 participants0 participants1 participants
Race/Ethnicity, Customized
White
65 participants33 participants98 participants
Sex: Female, Male
Female
51 Participants30 Participants81 Participants
Sex: Female, Male
Male
19 Participants7 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1380 / 690 / 720 / 36
other
Total, other adverse events
0 / 1380 / 690 / 720 / 36
serious
Total, serious adverse events
0 / 1380 / 690 / 720 / 36

Outcome results

Primary

Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)

VA was assessed for each eye individually using a Snellen chart at a distance of 4 meters. A 20/20 Snellen acuity is considered normal distance eyesight. No formal hypotheses were formulated; hence no inferential testing was performed.

Time frame: Dispense, Week 1, Week 2, Month 1, Month 2, Month 3

Population: Completed Analysis Set

ArmMeasureGroupValue (NUMBER)
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/2058 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/301 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/1574 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/2062 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/252 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/300 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/1575 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/254 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/1569 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/2065 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/254 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/300 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/1562 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/2072 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/254 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/300 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/1563 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/2068 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/257 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/300 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/1563 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/2069 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/256 eyes
DD T2Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/250 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/1531 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/253 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/1532 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/2040 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/2040 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/2037 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/250 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/251 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Dispense @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/1536 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/250 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/2036 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 1 @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 1 @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/300 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/1535 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/1533 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/2037 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 3 @ 20/1535 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/250 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Month 2 @ 20/2036 eyes
DT 1Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)Week 2 @ 20/300 eyes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026